RE:RE:RE:RE:made the TOP TEN BULLBOARDS AgainYes CancerSlayer you're right on that break the dollar and the rest will follar lol
CancerSlayer wrote
99942Apophis wrote: fasttrack5
Question is when will we make the top $
I will attempt to answer that question fasttrack5. The answer isn't what you want to hear, if Theralase forms partnerships along their journey as a sole company and maintains a major ownership its top dollar will continue to grow similar to other unique companies that have spread throughout the globe. In my biased opinion I can foresee an ever growing company as it conquers one cancer indication after another and as I suggested along its journey as a sole company with strategic partnerships, its share price will grow to what many could only fantasize, yes for sure hundreds perhaps eventually thousands! We all are aware how much is spent trying to treat various cancers but to think there is a treatment out there that only kills cancer and NOT healthy cells is worth what billions or trillions?
2nd part of your answer is what will the top dollar be if a buyout is offered once Theralase proves this isn't Snake Oil but the real body friendly super cancer killer? I think any offer over $100 cash per share with 1 for 1 share exchanged from the buyer, why because the value of conquering many cancer indications is worth a heck of a lot of money year after year after year.
Let's just break a US dollar for heaven's sake ; ) Actually, you omitted an equally wealth-building opportunity....That is, finally developing this tech/organometallic medicine to become a mainstream option as an antiviral or antibiotic. The scourge of drug/antibiotic-resistant infections has been a growing crisis for some time now. Our SOC antibiotics are simply becoming less effective due to antibiotic use/overuse (often used when not indicated) & the result of Darwinian tendencies in microorganisms. Many millions of people have died just in the last several years (either directly or indirectly) b/o antibiotic resistance, & these numbers will undoubtedly continue to rise imo.
There's a huge opportunity for a novel antibiotic/antiviral like that found in TLD-1433 or other organometallic (used with or without PDT) to either replace SOC therapy or help augment the fight against infectious disease...the potential for a goldmine here is no less than that of ACT imo. In a perfect world, you could add another zero to your price tag. For now, it's one milestone at a time & the sp will follow. Good luck...